Natural Killer Cell Therapy Shows Promise in Alzheimer's
Data from a small phase I study show significant clinical and biomarker activity of an investigational natural killer cell therapy in adults with AD, prompting a larger phase 2 trial.
Stay updated with breaking news from Iological Marker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data from a small phase I study show significant clinical and biomarker activity of an investigational natural killer cell therapy in adults with AD, prompting a larger phase 2 trial.
Facial expressions could be interpreted by computers as a biomarker of pain, research suggests.
New data from TRAILBLAZER-ALZ 2 show robust amyloid clearance with donanemab in APOE4 carriers and noncarriers, mitigating the risk of disease progression and dependency.
Using metabolic biomarkers, researchers have developed a blood test that accurately identifies bipolar disorder in patients misdiagnosed with major depressive disorder, new research shows.
Researchers described ongoing work to "understand the discrete and overlapping endotypes that underlie the phenotypes" of psoriatic disease and to develop a diagnostic test for psoriatic arthritis.